Category: Health Care Costs

New Data Brief on Hospital Consolidation and Premiums

The growing body of evidence that hospital consolidation and higher premiums go hand-in-hand has yet another entry. A new AHIP data brief finds that as hospital consolidation increases, so too do premiums. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Rx News Roundup: Lower Prices and More Transparency

Leading oncologists are challenging exorbitant drug prices and making headlines this week by unveiling new tools aimed at driving value in cancer care. Continue reading

Posted in: Health Care Costs

Nearly $1 trillion in the next 5 years

Global prescription drug sales will grow 4.8 percent a year until reaching $987 billion by 2020, according to a new report from EvaluatePharma. Other findings from the report upend the concept that that research and development costs are driving high prescription drug prices. Continue reading

Posted in: Health Care Costs, Uncategorized

AHIP Briefing: Focus on the Price

Several stakeholders gathered in Washington, D.C., this morning for a panel discussion titled “Cost of Innovation: How the Future Drug Pipeline Will Impact Patient Access, Affordability.” Continue reading

Posted in: Health Care Costs

$50 billion is just the tip of the iceberg

With roughly 5,400 drugs in the pipeline, the issue of sustainable pricing is more important than ever. Continue reading

Posted in: Health Care Costs

Too Expensive

While drug manufacturers turn a blind eye to the fact that they charge some of the highest prices in the world, patients are paying attention – and they’re not happy about it. Continue reading

Posted in: Health Care Costs, Uncategorized

Let’s get serious about affordability

How do we rein in unsustainable prices for medical services and treatments to keep care within reach for patients? Continue reading

Posted in: Cost Alert, Health Care Costs

Innovative medical cures and affordability: The health care dilemma

Today the Partnership for Quality Care held a forum on sustainable prescription drug pricing – something that we need but still don’t have, according to the panelists. Continue reading

Posted in: Health Care Costs

The Discussion About Access We Need To Have

To provide the affordable coverage that consumers want, all stakeholders have to be willing to embrace the goal of affordability and work together to achieve it. This means that the old ways have to change. Continue reading

Posted in: Health Care Costs, Issue Alert, Uncategorized

This isn’t a game of monopoly

Ever rising prescription drug prices mean more expensive coverage for individuals, families, and employers. Many of the astronomical price tags for medicines can be traced back to business practices that promote monopoly-like pricing rather than improved patient access. Continue reading

Posted in: Health Care Costs, Issue Alert